0
ARTICLE |

Bleeding Problems-Reply

Richard Gleckman, MD; Nelson M. Gantz, MD
Arch Intern Med. 1983;143(1):184. doi:10.1001/archinte.1983.00350010195048.
Text Size: A A A
Published online

In Reply.  —The first-generation cephalosporins have enjoyed wide popularity as prophylactic agents to prevent postoperative infections in specific surgical procedures classified as "clean" and "clean-contaminated."1 The universal application of these agents for these defined indications can be attributed to the following factors: these antibiotics are nontoxic, relatively inexpensive, and possess activity for those major pathogens (ie, Staphylococcus aureus or coliforms) likely to be encountered in the operative area. Confirmation of their efficacy in selective procedures has been repeatedly documented in prospective, randomized, controlled studies.2,3We believe the third-generation cephalosporins are not indicated for perioperative prophylaxis. These compounds exert less activity for S aureus. Although the third-generation cephalosporins exert greater activity against the Enterobacteriaceae than the first-generation or second-generation cephalosporins, the preferred prophylactic agent need not be active against every bacterial species present. Third-generation cephalosporins are considerably more expensive than first-generation cephalosporins, and no study has proved their clinical

Sign In to Access Full Content

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

Purchase Online Access to this article for 24 hours

Figures

Tables

Interactive Graphics

Video

Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature

Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal

References

Correspondence

CME
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s “Cited By” API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Comment

Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs